Table 3.
The relationship between the expressions of iNOS and VEGF and the prognosis of gastric carcinoma
n |
survival period |
rate of five-year surviva (%) | ||
< 5 years | > 5 years | |||
iNOS expession | ||||
Positive | 27 | 22 | 5 | 18.52a |
Negative | 19 | 10 | 9 | 47.37 |
VEGF expession | ||||
Positive | 35 | 30 | 5 | 14.29b |
Negative | 11 | 5 | 6 | 54.55 |
P < 0.05, (χ² = 4.3842), vs the iNOS-negative gastric cancer patients;
P < 0.05, (χ² = 5.4073, vs the VEGF-negative gastric cancer patients.